Trestle Biotherapeutics
PrivateLast Round
Grant
Jun 12, 2023
Est. Valuation
$1.79M
Total Funding Raised
$1.13M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Trestle Biotherapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in June 2023.
Trestle Biotherapeutics is a biotechnology company that develops bioengineered kidney tissues to treat patients with end-stage renal disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trestle Biotherapeutics Comparables
Compare Trestle Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Satellite Bio | 82% | |
| Rege Nephro Co., Ltd. | 79% | |
| LiveKidney.BIO | 79% |
For institutional investors. Book with your work email.
Trestle Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 12, 2023 | ||||
| Accelerator | Jan 5, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trestle Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
| Kidney Innovation Accelerator | Grant |
| C3 Ventures | Accelerator |
| Black Mountain Ventures | Accelerator |
| Formic Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 273% MoM, reaching 4.4K.
- Jun 21, 2026
Monthly visitors grew 48% MoM.
For institutional investors. Book with your work email.
Trestle Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trestle Biotherapeutics's valuation, stock price, and market status.
Is Trestle Biotherapeutics a public or private company?
Trestle Biotherapeutics is a private company.
What is the current stock price of Trestle Biotherapeutics?
Trestle Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Trestle Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trestle Biotherapeutics worth (valuation)?
Trestle Biotherapeutics's valuation is estimated at $1.8M based on funding round data.
Can I buy Trestle Biotherapeutics stock?
Trestle Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trestle Biotherapeutics's last funding round?
Trestle Biotherapeutics's most recent funding round was Grant on June 12, 2023.
Who are the main investors in Trestle Biotherapeutics?
Key investors in Trestle Biotherapeutics include Y Combinator.
Will Trestle Biotherapeutics IPO soon?
No public IPO plans have been announced for Trestle Biotherapeutics.
How can I track Trestle Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Trestle Biotherapeutics's shares on secondary markets.